Dr. Alessandro Prigione
Dr. Prigione is an Independent Team Leader at the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. He received an MD from the University of Milan in 2002 and a PhD from the University of Milan-Bicocca in 2008.
The Prigione group was established in 2015 with the support of a Junior Investigator grant from the German Ministry of Education and Research (BMBF). The lab focus is to develop induced pluripotent stem cells (iPSC)-based approaches for modeling and treatment discovery of neurological diseases causing mitochondrial impairment.
Dr. Prigione is a Delbrueck Fellow since 2013 and a recipient of the Career Advancement Initiative from the Journal of Molecular Biology in 2017. He has published 49 scientific articles (h-index: 25). His latest work (Lorenz et al, Cell Stem Cell2017) demonstrated the use of iPSC-derived neural progenitors for drug discovery of neurological conditions caused by mitochondrial DNA mutations.